Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05198284 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05198284 · ClinicalTrials.gov record · last posted 2026-08-13

Prospective Decision Impact Clinical Utility Trial of KidneyIntelX

StatusActive, Not Recruiting
PhaseNot specified
Started2021-11-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The clinical utility trial is designed to evaluate how the results of KidneyIntelX test / platform impacts on the clinical management of type 2 diabetes patients identified as increased risk for rapid kidney function decline within 5-years.

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2022-01-05; most recent amendment 2024-04-11. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-04-11
Status change Recruiting→Active, Not Recruitingv2
Trial Details
NCT Number NCT05198284
Lead Sponsor Renalytix AI, Inc.
Conditions Diabetic Kidney Disease, Chronic Kidney Diseases, Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3
Enrollment 2,000 participants
Start Date 2021-11-01
Primary Completion 2023-12-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-13